Centiva Capital’s West Pharmaceutical WST Stock Holding History

Centiva Capital’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-5,802	Closed	-$1.74M	–	2475
2024 Q3	$1.74M	Buy	5,802 +1,326	+30%	+$406K	0.03%	519
2024 Q2	$1.47M	Buy	+4,476	New	+$1.58M	0.03%	574
2024 Q1	–	Sell	-5,364	Closed	-$1.89M	–	2324
2023 Q4	$1.89M	Buy	5,364 +4,168	+348%	+$1.48M	0.04%	373
2023 Q3	$449K	Buy	+1,196	New	+$463K	0.01%	1001
2023 Q1	–	Sell	-1,752	Closed	-$412K	–	1889
2022 Q4	$412K	Buy	+1,752	New	+$415K	0.01%	831
2022 Q2	–	Sell	-2,581	Closed	-$1.06M	–	2033
2022 Q1	$1.06M	Buy	+2,581	New	+$1.01M	0.02%	674
2021 Q3	–	Sell	-3,124	Closed	-$1.12M	–	1647
2021 Q2	$1.12M	Buy	+3,124	New	+$1.03M	0.03%	525
2020 Q4	–	Sell	-771	Closed	-$212K	–	1126
2020 Q3	$212K	Buy	+771	New	+$204K	0.01%	580

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Centiva Capital's WST Position: Q4 2024 in Review

Centiva Capital sold out of West Pharmaceutical (WST) in Q4 2024, closing a stake of 5,802 shares — an estimated $1.74M sold.

Centiva Capital first reported a position in WST in Q3 2020 and held it in 8 quarters. The position peaked at $1.89M in Q4 2023. 748 funds tracked by Wall St. Rank hold WST as of Q4 2024.

Centiva Capital reported no remaining West Pharmaceutical position as of Q4 2024 after selling out during the quarter.
Centiva Capital sold 5,802 West Pharmaceutical shares in Q4 2024, an estimated $1.74M.
Centiva Capital first reported a position in West Pharmaceutical in Q3 2020 and held it in 8 quarters.
Centiva Capital's West Pharmaceutical position peaked at $1.89M in Q4 2023.
748 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2024.

Based on Centiva Capital's 13F filing for Q4 2024, filed 14 Feb 2025.